Non-PVC IV Bags

Global Non-PVC IV Bags Market to Reach US$4.6 Billion by 2030

The global market for Non-PVC IV Bags estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Single-Chamber, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Multi-Chamber segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$820.0 Million While China is Forecast to Grow at 7.2% CAGR

The Non-PVC IV Bags market in the U.S. is estimated at US$820.0 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$711.3 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Non-PVC IV Bags Market - Key Trends and Drivers Summarized

How Are Non-PVC IV Bags Redefining Medical Fluid Delivery?

Non-PVC (polyvinyl chloride) IV bags are becoming increasingly popular in healthcare settings due to their safety, environmental benefits, and compatibility with a wide range of fluids. Unlike traditional PVC-based IV bags, non-PVC bags are made from materials like polypropylene, polyethylene, and ethylene-vinyl acetate (EVA), which are free from harmful plasticizers such as DEHP (di-2-ethylhexyl phthalate). This eliminates the risk of chemical leaching, making non-PVC IV bags safer for patients, especially in sensitive applications like oncology, neonatal care, and parenteral nutrition. With growing concerns over patient safety and the environmental impact of medical waste, non-PVC IV bags are setting a new standard for intravenous fluid administration.

What Are the Key Segments in the Non-PVC IV Bags Market?

Major materials include polypropylene, EVA, and polyethylene, with polypropylene dominating the market due to its durability, transparency, and chemical resistance. The capacity segment covers small (50–250 ml), medium (250–500 ml), and large (500 ml and above) bags, catering to different patient needs and medical procedures. In terms of application, non-PVC IV bags are used for chemotherapy, blood transfusions, parenteral nutrition, and other infusion therapies. The rising demand for these applications, coupled with the increasing focus on safety and sustainability, has contributed to the rapid growth of this market.

How Are Non-PVC IV Bags Being Adopted Across Healthcare?

Hospitals and healthcare facilities are the primary adopters of non-PVC IV bags, integrating them into various treatments to reduce the risk of chemical exposure and improve patient outcomes. In oncology departments, non-PVC IV bags are used for administering chemotherapy drugs, as they prevent drug interactions and ensure the stability of sensitive medications. In neonatal and pediatric care, these bags minimize the risk of exposure to harmful plasticizers, making them safer for vulnerable patients. Pharmaceutical manufacturers are also embracing non-PVC IV bags for packaging injectable drugs, especially biologics and vaccines, where maintaining drug integrity is critical. Additionally, home healthcare services are increasingly using non-PVC IV bags for parenteral nutrition and hydration therapy, aligning with the growing trend of remote care.

What Factors Are Driving the Growth in the Non-PVC IV Bags Market?

The growth in the Non-PVC IV Bags market is driven by several factors, including increasing concerns over the safety of PVC and the potential risks of plasticizer leaching. The shift towards safer and more sustainable medical supplies has prompted healthcare providers to adopt non-PVC alternatives. Technological advancements in material science have improved the quality and compatibility of non-PVC bags, making them suitable for a wider range of medications and infusion therapies. The rising prevalence of chronic diseases and the growing demand for parenteral nutrition are also boosting the market. Additionally, regulatory support and initiatives to reduce medical waste have accelerated the transition to non-PVC IV bags, contributing to their growing adoption in hospitals, clinics, and home healthcare settings.

SCOPE OF STUDY:

The report analyzes the Non-PVC IV Bags market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Single-Chamber, Multi-Chamber); Content Type (Liquid Mixture, Frozen Mixture); Material (Ethylene Vinyl Acetate, Copolyester Ether, Polypropylene, Other Materials)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

• Angiplast Pvt. Ltd.
• B.Braun
• Baxter
• Beijing Double Crane
• Cryovac Inc. (Sealed Air)
• Fresenius Group
• Huaren Pharmaceutical
• Jiangxi Sanxin Medtec Co., Ltd.
• Kelun Group
• Kraton Corporation
• Otsuka
• PolyCine GmbH
• Renolit
• Sartorius Stedim Biotech
• Shanghai Solve Care Co., Ltd.
• Shanghai Xin Gen Eco-Technologies Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.